During the past few years we are hearing more and more about our society being obese and overweight. According to the Health, United States 2005, a CDC report, 31 percent of adult Americans are ...

Benefits seen for lower risk for type 2 diabetes, dyslipidemia, bariatric surgery, and mortality. HealthDay News — A positive response to treatment for pediatric obesity has enduring health benefits ...

Drugs like Wegovy and Zepbound are approved by the U.S. Food and Drug Administration (FDA) for those with overweight or obesity and dyslipidemia. Quitting smoking. Quitting smoking can improve ...

About The Study: This cohort study demonstrated that good response to pediatric obesity treatment was associated with reduced long-term morbidity, such as type 2 diabetes, dyslipidemia ...

insulin resistance and dyslipidemia. To date, the data are strongest for hypertension, while data for adverse glucose or lipid metabolism are more controversial. Obesity and other factors ...

dyslipidemia, weight-loss bariatric surgery, and depression or anxiety outcomes tended to decrease with better treatment response but were still higher than the general population. Obesity ...

Untreated hypercortisolemia causes significant morbidity and increased mortality due to its metabolic effects including hypertension, osteoporosis, obesity, dyslipidemia, osteoporosis and glucose ...

Treatment responses were classified as poor, intermediate, good, or obesity remission. Health outcomes assessed included hypertension, type 2 diabetes, dyslipidemia, anxiety or depression ...

Achieving obesity remission reduced children’s and teens’ risk for developing type 2 diabetes, hypertension and dyslipidemia in adulthood, according to findings from a study published in JAMA ...